These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 12717415

  • 1. v-Jun stimulates both cdk2 kinase activity and G1/S progression via transcriptional repression of p21 CIP1.
    Maclaren A, Clark W, Black EJ, Gregory D, Fujii H, Gillespie DA.
    Oncogene; 2003 Apr 24; 22(16):2383-95. PubMed ID: 12717415
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US, Park SK, Lee YI, Park JG, Lee YI.
    Oncogene; 2000 Jul 13; 19(30):3384-94. PubMed ID: 10918595
    [Abstract] [Full Text] [Related]

  • 3. Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest.
    Burdon D, Patel R, Challiss RA, Blank JL.
    Biochem J; 2002 Oct 15; 367(Pt 2):549-59. PubMed ID: 12126481
    [Abstract] [Full Text] [Related]

  • 4. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB, Kislyakova TV, Aksenov ND, Osipov KA, Pospelov VA.
    Oncogene; 2000 Aug 10; 19(34):3858-65. PubMed ID: 10951579
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G, Habbersett RC, Jia Y, Peterson SR, Lehnert BE, Bradbury EM, D'Anna JA.
    Oncogene; 1998 Feb 12; 16(6):721-36. PubMed ID: 9488036
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficient down-regulation of cyclin A-associated activity and expression in suspended primary keratinocytes requires p21(Cip1).
    Hauser P, Ma L, Agrawal D, Haura E, Cress WD, Pledger WJ.
    Mol Cancer Res; 2004 Feb 12; 2(2):96-104. PubMed ID: 14985466
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. NS1- and minute virus of mice-induced cell cycle arrest: involvement of p53 and p21(cip1).
    Op De Beeck A, Sobczak-Thepot J, Sirma H, Bourgain F, Brechot C, Caillet-Fauquet P.
    J Virol; 2001 Nov 12; 75(22):11071-8. PubMed ID: 11602746
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1.
    Miyazaki M, Ohashi R, Tsuji T, Mihara K, Gohda E, Namba M.
    Biochem Biophys Res Commun; 1998 May 29; 246(3):873-80. PubMed ID: 9618305
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
    Fotedar R, Fitzgerald P, Rousselle T, Cannella D, Dorée M, Messier H, Fotedar A.
    Oncogene; 1996 May 16; 12(10):2155-64. PubMed ID: 8668341
    [Abstract] [Full Text] [Related]

  • 17. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.
    Crowe DL, Brown TN, Kim R, Smith SM, Lee MK.
    Mol Cell Biol Res Commun; 2000 Apr 16; 3(4):243-8. PubMed ID: 10891399
    [Abstract] [Full Text] [Related]

  • 18. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation.
    Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, Mizutani S.
    EMBO J; 1999 Mar 01; 18(5):1223-34. PubMed ID: 10064589
    [Abstract] [Full Text] [Related]

  • 19. Effects of ectopic overexpression of p21(WAF1/CIP1) on aneuploidy and the malignant phenotype of human brain tumor cells.
    Chen J, Willingham T, Shuford M, Bruce D, Rushing E, Smith Y, Nisen PD.
    Oncogene; 1996 Oct 03; 13(7):1395-403. PubMed ID: 8875977
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.